Interleukin 4 inhibits murine osteoclast formation in vitro

J Cell Biochem. 1991 Nov;47(3):272-7. doi: 10.1002/jcb.240470313.

Abstract

Interleukin 4 (IL-4) is a product of activated T cells and mast cells with effects on immunologic and hematopoietic processes. We now report that IL-4 inhibits the formation of osteoclasts from murine bone marrow cells cocultured with stromal cells. Numerous (3,000-4,000 cells/2 cm2) tartrate-resistant acid-phosphatase-positive multinucleated cells with the capacity to generate cAMP in response to salmon calcitonin (ED50 = 10(-10) M) developed within 10-12 days of culture. IL-4 (ID50 = 10 U/ml) inhibited osteoclast generation in doses similar to those that induce proliferation of IL-4-responsive T cells. Additionally, the rat antimurine IL-4 monoclonal antibody 11B11 antagonizes the IL-4-inhibitory effect on osteoclast formation. These results suggest that IL-4 impedes agonist-induced in vitro bone resorption by inhibiting osteoclastogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal
  • Biomarkers
  • Bone Marrow / drug effects*
  • Bone Marrow Cells
  • Bone Remodeling / physiology
  • Calcitonin / pharmacology
  • Cell Differentiation / drug effects
  • Cell Division
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Interleukin-4 / immunology
  • Interleukin-4 / pharmacology*
  • Lymphocyte Activation / physiology
  • Mice
  • Osteoclasts / drug effects*
  • T-Lymphocytes / cytology
  • T-Lymphocytes / drug effects

Substances

  • Antibodies, Monoclonal
  • Biomarkers
  • Interleukin-4
  • Calcitonin
  • Cyclic AMP